Patents by Inventor Lianqiang JIANG

Lianqiang JIANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11608502
    Abstract: The invention belongs to the field of genetic engineering technology and application thereof, and in order to solve the problems of lack of high efficient TMV-resistant RNAi nano-preparation at present, complicated preparation process of medicament, poor stability and delivery efficiency of dsRNA, the invention provides an RNAi nano-preparation, preparation method thereof and application thereof in TMV prevention and control. The RNAi nano-preparation is prepared from dsRNA and chitosan nano materials, wherein, dsRNA is a highly TMV-resistant RdRP3 gene with a length of 313 bp obtained from screening, with nucleotide sequence shown in SEQ ID NO.1, and the volume ratio of the chitosan to 1 ?g/?l dsRNA is 10:(1-6).
    Type: Grant
    Filed: August 20, 2020
    Date of Patent: March 21, 2023
    Assignees: TOBACCO RESEARCH INSTITUTE OF CHINESE ACADEMY OF AGRICULTURAL SCIENCES, SICHUAN BRANCH OF CHINA TOBACCO, LIANGSHAN BRANCH OF SICHUAN TOBACCO
    Inventors: Jinguang Yang, Fenglong Wang, Xiang Xu, Ying Li, Liyun Song, Lili Shen, Qiang Lei, Changchun Feng, Bin Li, Yong Wang, Dongyang Liu, Lianqiang Jiang
  • Patent number: 11375718
    Abstract: The present invention belongs to the technical field of application of microbial secondary metabolites, and particularly relates to novel use of prodigiosin in resisting potato virus Y. Application of prodigiosin in preparing a medicine for preventing and controlling potato virus Y. The medicine for preventing and controlling the potyvirus is a liquid or solid preparation containing prodigiosin. It is clarified that PVY promotes its own replication and infection by recruiting host factor Hsp70 in the process of infecting the host, realizing virus infection and spread. Hsp70 plays an important role in the infection and replication of plant viruses. Based on the above results, it is further clarified that prodigiosin treatment can significantly increase the ubiquitination level of the plant host, promote the ubiquitination of HSP70 protein of the host, degrade or inhibit the expression of Hsp70 protein, activate the natural immune activity of the host plant.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: July 5, 2022
    Assignees: Liangshan Branch of Sichuan Tobacco, Sichuan Branch of China Tobacco, Tobacco Resarch Inst. of Chi. Acad. of Agr. Sci
    Inventors: Jinguang Yang, Fenglong Wang, Xiang Xu, Ying Li, Liyun Song, Lili Shen, Qiang Lei, Changchun Feng, Bin Li, Yong Wang, Dongyang Liu, Lianqiang Jiang
  • Publication number: 20210400965
    Abstract: The present invention belongs to the technical field of application of microbial secondary metabolites, and particularly relates to novel use of prodigiosin in resisting potato virus Y. Application of prodigiosin in preparing a medicine for preventing and controlling potato virus Y. The medicine for preventing and controlling the potyvirus is a liquid or solid preparation containing prodigiosin. It is clarified that PVY promotes its own replication and infection by recruiting host factor Hsp70 in the process of infecting the host, realizing virus infection and spread. Hsp70 plays an important role in the infection and replication of plant viruses. Based on the above results, it is further clarified that prodigiosin treatment can significantly increase the ubiquitination level of the plant host, promote the ubiquitination of HSP70 protein of the host, degrade or inhibit the expression of Hsp70 protein, activate the natural immune activity of the host plant.
    Type: Application
    Filed: September 25, 2020
    Publication date: December 30, 2021
    Inventors: Jinguang YANG, Fenglong WANG, Xiang XU, Ying Li, Liyun Song, Lili SHEN, Qiang LEI, Changchun FENG, Bin LI, Yong WANG, Dongyang LIU, Lianqiang JIANG
  • Publication number: 20210363529
    Abstract: The invention belongs to the field of genetic engineering technology and application thereof, and in order to solve the problems of lack of high efficient TMV-resistant RNAi nano-preparation at present, complicated preparation process of medicament, poor stability and delivery efficiency of dsRNA, the invention provides an RNAi nano-preparation, preparation method thereof and application thereof in TMV prevention and control. The RNAi nano-preparation is prepared from dsRNA and chitosan nano materials, wherein, dsRNA is a highly TMV-resistant RdRP3 gene with a length of 313 bp obtained from screening, with nucleotide sequence shown in SEQ ID NO.1, and the volume ratio of the chitosan to 1 ?g/?l dsRNA is 10:(1-6).
    Type: Application
    Filed: August 20, 2020
    Publication date: November 25, 2021
    Inventors: Jinguang YANG, Fenglong WANG, Xiang XU, Ying LI, Liyun SONG, Lili SHEN, Qiang LEI, Changchun FENG, Bin LI, Yong WANG, Dongyang LIU, Lianqiang JIANG